tradingkey.logo

Artivion Inc

AORT
46.600USD
-0.550-1.17%
Cierre 12/19, 16:00ETCotizaciones retrasadas 15 min
2.21BCap. mercado
PérdidaP/E TTM

Más Datos de Artivion Inc Compañía

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Información de Artivion Inc

Símbolo de cotizaciónAORT
Nombre de la empresaArtivion Inc
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMackin (James Patrick)
Número de empleados1600
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 12
Dirección1655 Roberts Boulevard N W
CiudadKENNESAW
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal30144
Teléfono17704193355
Sitio Webhttps://artivion.com/
Símbolo de cotizaciónAORT
Fecha de salida a bolsaFeb 12, 1993
Director ejecutivoMackin (James Patrick)

Ejecutivos de Artivion Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
178.56K
-5.27%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-4.06%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
33.50K
-18.53%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
178.56K
-5.27%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-4.06%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+10.09%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Aortic stent grafts
39.84M
35.27%
On X
25.57M
22.64%
Preservation Services
25.53M
22.60%
Bio Glue
19.29M
17.07%
Surgical sealants
19.29M
17.07%
Other
2.74M
2.43%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.38%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Otro
66.27%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.38%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Otro
66.27%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.10%
Investment Advisor/Hedge Fund
28.30%
Individual Investor
4.35%
Private Equity
4.26%
Hedge Fund
3.33%
Research Firm
1.87%
Pension Fund
1.05%
Bank and Trust
0.37%
Family Office
0.04%
Otro
4.32%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
2023Q3
319
34.91M
90.03%
-219.54K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
5.54M
11.75%
-205.09K
-3.57%
Jun 30, 2025
The Vanguard Group, Inc.
2.79M
5.91%
+16.34K
+0.59%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.20M
4.66%
-584.24K
-21.00%
Jun 30, 2025
Nomura Investment Management Business Trust
2.96M
6.27%
+52.54K
+1.81%
Jun 30, 2025
Perceptive Advisors LLC
2.79M
5.92%
--
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
1.93M
4.09%
-9.84K
-0.51%
Jun 30, 2025
State Street Investment Management (US)
1.51M
3.21%
-17.10K
-1.12%
Jun 30, 2025
Wellington Management Company, LLP
1.71M
3.63%
-13.99K
-0.81%
Jun 30, 2025
Juniper Investment Company, LLC
1.86M
3.95%
-229.50K
-10.96%
Aug 08, 2025
Fred Alger Management, LLC
1.35M
2.86%
+1.23M
+1018.31%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
Ver más
AAM Sawgrass US Small Cap Quality Growth ETF
Proporción4.14%
Unusual Whales Subversive Democratic Trading ETF
Proporción3.4%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.85%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.74%
Invesco S&P SmallCap Health Care ETF
Proporción1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción0.69%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0.42%
iShares Micro-Cap ETF
Proporción0.33%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Artivion Inc?

Los cinco principales accionistas de Artivion Inc son:
BlackRock Institutional Trust Company, N.A. posee 5.54M acciones, lo que representa el 11.75% del total de acciones.
The Vanguard Group, Inc. posee 2.79M acciones, lo que representa el 5.91% del total de acciones.
Fidelity Management & Research Company LLC posee 2.20M acciones, lo que representa el 4.66% del total de acciones.
Nomura Investment Management Business Trust posee 2.96M acciones, lo que representa el 6.27% del total de acciones.
Perceptive Advisors LLC posee 2.79M acciones, lo que representa el 5.92% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Artivion Inc?

Los tres principales tipos de accionista de Artivion Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC

¿Cuántas instituciones poseen acciones de Artivion Inc (AORT)?

A fecha de 2025Q4, 410 instituciones poseen acciones de Artivion Inc, con un valor de mercado combinado de aproximadamente 43.29M, lo que representa el 91.25% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.24%.

¿Cuál es la mayor fuente de ganancias de Artivion Inc?

El FY2025Q2, el segmento empresarial Aortic stent grafts generó la ganancia más alta para Artivion Inc, ascendiendo a 39.84M y representando el 35.27% de la ganancia total.
KeyAI